Open Access
Issue
J Extra Corpor Technol
Volume 56, Number 2, June 2024
Page(s) 37 - 44
DOI https://doi.org/10.1051/ject/2024003
Published online 18 June 2024
  1. Bartoszko J, Karkouti K. Managing the coagulopathy associated with cardiopulmonary bypass. J Thromb Haemost 2021;19(3):617–632. [CrossRef] [PubMed] [Google Scholar]
  2. Maisat W, Yuki K. Narrative review of systemic inflammatory response mechanisms in cardiac surgery and immunomodulatory role of anesthetic agents. Ann Card Anaesth 2023;26(2):133–142. [CrossRef] [PubMed] [Google Scholar]
  3. Fukui T, Nishida H, Takanashi S. Biocompatibility of cardiopulmonary bypass circuit with new polymer Senko E-Ternal Coating. Perfusion 2015;30(7):572–9. [CrossRef] [PubMed] [Google Scholar]
  4. Yun SH, Sim EH, Goh RY, Park JI, Han JY. Platelet activation: the mechanisms and potential biomarkers. Biomed Res Int 2016;2016:9060143. [PubMed] [Google Scholar]
  5. Hanedan MO, Yürük MA, Arslan AK, Kılıç A, Sayar U, Mataracı İ. Heparin-coated vs. non-coated cardiopulmonary bypass circuits: comparing immediate results with different target activated clotting time. Braz. J Cardiovasc Surg 2020;35(6):913–917. [Google Scholar]
  6. Hosoyama K, Ito K, Kawamoto S, et al. Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery. J Artif Organs 2016;19(3):233–40. [CrossRef] [PubMed] [Google Scholar]
  7. Lu Q, Hofferbert BV, Koo G, Malinauskas RA. In vitro shear stress-induced platelet activation: sensitivity of human and bovine blood. Artif Organs 2013;37(10):894–903. [CrossRef] [PubMed] [Google Scholar]
  8. Lax M, Pesonen E, Hiippala S, Schramko A, Lassila R, Raivio P. Heparin dose and point-of-care measurements of hemostasis in cardiac surgery-results of a randomized controlled trial. J Cardiothorac Vasc Anesth 2020;34(9):2362–2368. [CrossRef] [PubMed] [Google Scholar]
  9. Vukicevic P, Klisic A, Neskovic V, et al. New markers of platelet activation and reactivity and oxidative stress parameters in patients undergoing coronary artery bypass grafting. Oxid Med Cell Longev 2021;2021:8915253. [PubMed] [Google Scholar]
  10. Epstein D, Vishnepolsky A, Bolotin G, Atweh N, Bonstein L, Lehavi A. Effect of prolonged hypothermic cardiopulmonary bypass, heparin, and protamine on platelet: a small-group study. Thorac Cardiovasc Surg 2021;69(8):719–722. [CrossRef] [PubMed] [Google Scholar]
  11. Jamiolkowski MA, Patel M, Golding MD, Malinauskas RA, Lu Q. Comparison of animal and human blood for in vitro dynamic thrombogenicity testing of biomaterials. Artif Organs 2022;46(12):2400–2411. [CrossRef] [PubMed] [Google Scholar]
  12. Kocakulak M, Koçum C, Saber R, et al. Investigation of blood compatibility of PMEA coated extracorporeal circuits. J Bioact Compat Polym 2002;17(5):343–356. [CrossRef] [Google Scholar]
  13. Jenke A, Yazdanyar M, Miyahara S, et al. AdipoRon attenuates inflammation and impairment of cardiac function associated with cardiopulmonary bypass-induced systemic inflammatory response syndrome. J Am Heart Assoc 2021;10(6):e018097. [CrossRef] [PubMed] [Google Scholar]
  14. Nagy B Jr., Debreceni IB, Kappelmayer J. Flow cytometric investigation of classical and alternative platelet activation markers. EJIFCC 2013;23(4):124–34. [PubMed] [Google Scholar]
  15. French DL, Seligsohn U. Platelet glycoprotein IIb/IIIa receptors and Glanzmann’s thrombasthenia. Arterioscler Thromb Vasc Biol. 2000;20(3):607–10. [CrossRef] [PubMed] [Google Scholar]
  16. Chen Z, Mondal NK, Ding J, et al. Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress. Mol Cell Biochem 2015;409(1–2):93–101. [CrossRef] [PubMed] [Google Scholar]
  17. Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007;100(12):1673–85. [CrossRef] [PubMed] [Google Scholar]
  18. Neubauer K, Zieger B. Endothelial cells and coagulation. Cell Tissue Res 2022;387(3):391–398. [CrossRef] [PubMed] [Google Scholar]
  19. Fox SC, May JA, Dovlatova N, et al. How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy? Platelets 2019;30(3):290–295. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.